Research Collaborations
StemCells collaborates with prominent researchers and clinicians at leading academic institutions and medical centers. Below is a listing of current and recent collaborators:
- Stanford University and Stanford School of Medicine
- StemCells has a long history of collaboration with Stanford University and Stanford School of Medicine in the areas of CNS disorders and liver disease.
- We are currently collaborating with Jeffrey Glenn, MD, PhD, associate professor of Gastroenterology and Hepatology at Stanford University School of Medicine to study the therapeutic potential of our hLEC™ cells in hepatitis C. This research is supported by a $400,000 National Institutes of Health (NIH) grant.
- We have also conducted preliminary studies in collaboration with Raphael Guzman, MD and Gary Steinberg, MD, PhD, both professors of Neurosurgery at Stanford University School of Medicine, to study the therapeutic potential of our human neural stem cells in stroke.
- UC Irvine
- StemCells has conducted extensive preclinical studies in spinal cord injury in collaboration with Aileen J. Anderson, PhD and Brian J. Cummings, PhD, both associate professors in the Departments of Physical Medicine and Rehabilitation, and Anatomy and Neurobiology at the University of California, Irvine (UC Irvine).
- StemCells is also currently conducting a research collaboration in Alzheimer's disease with Frank LaFerla, PhD, Director of the UC Irvine Institute for Memory Impairments and Neurological Disorders (UCI MIND), and Chancellor's professor, Neurobiology and Behavior in teh School of Biological Sciences at UC Irvine.
- OHSU Casey Eye Institute
- StemCells has conducted preclinical studies of our human neural stem cells in retinal disorders in collaboration with Raymond Lund, PhD, professor of Opthalmology at the Casey Eye Institute at Oregon Health & Science University (OHSU).
- McLaughlin Research Institute
- StemCells has collaborated with George A. Carlson, PhD, professor and director of the McLaughlin Research Institute in Great Falls, Montana to study the therapeutic potential of our human neural stem cells in Alzheimer’s disease.
